Citation: E. Lindhoff-last et al., Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients, CL APPL T-H, 7(4), 2001, pp. 300-304
Authors:
Lindhoff-Last, E
Gerdsen, F
Ackermann, H
Bauersachs, R
Citation: E. Lindhoff-last et al., Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia, BR J HAEM, 113(4), 2001, pp. 886-890
Authors:
Lindhoff-Last, E
Eichler, P
Stein, M
Plagemann, J
Gerdsen, F
Wagner, R
Ehrly, AM
Bauersachs, R
Citation: E. Lindhoff-last et al., A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery, THROMB RES, 97(6), 2000, pp. 387-393
Authors:
Lindhoff-Last, E
Piechottka, GP
Rabe, F
Bauersachs, R
Citation: E. Lindhoff-last et al., Hirudin determination in plasma can be strongly influenced by the prothrombin level, THROMB RES, 100(1), 2000, pp. 55-60